UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 15, 2013 (November 14, 2013)
GUIDED THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| | | |
| Delaware | 0-22179 | 58-2029543 |
| (State or Other Jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) |
| Incorporation) | | |
Registrant’s telephone number, including area code:(770) 242-8723
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | [ ]Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | [ ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | [ ]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | [ ]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2.02 Results of Operations and Financial Condition
On November 14, 2013, the registrant publicly released its financial results for the third quarter and nine months ended September 30, 2013, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto and which information is incorporated herein by reference.
Section 7.01 (Regulation FD Disclosure)
On November 15, 2013, the registrant conducted a conference call discussing its financial results for the third quarter and nine months ended September 30, 2013 and other matters concerning the operation of the company, as more fully described in the prepared transcript of the call, a copy of which is furnished as Exhibit 99.2 hereto and which information is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
| | |
| Number | Exhibit |
| | |
| 99.1 | Press Release dated November 14, 2013 |
| 99.2 | Transcript of Conference Call held on November 15, 2013 |
| | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | GUIDED THERAPEUTICS, INC. |
| | |
| | /s/ Mark L. Faupel, Ph.D. |
| | By: Mark L. Faupel, Ph.D. |
| | CEO & President |
| | |
| Date: November 15, 2013 | |
